PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.750
-0.150 (-3.06%)
At close: Oct 16, 2026, 4:00 PM EDT
4.900
+0.150 (3.16%)
After-hours: Oct 16, 2026, 7:55 PM EDT
PolyPid Market Cap
PolyPid has a market cap or net worth of $95.87 million as of October 16, 2026. It is the 25,567th most valuable company in the world and the 4,124th biggest in the United States. Its market cap has increased by 80.29% in one year.
Market Cap
95.87M
Enterprise Value
90.88M
1-Year Change
80.29%
Global Rank
Country Rank
#4,124 United States
Category
ChartMarket Cap Chart
Since June 26, 2020, PolyPid's market cap has increased from $82.43M to $95.87M, an increase of 16.30%. That is a compound annual growth rate of 2.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 95.87M | 32.80% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 99.70M |
| Milestone Pharmaceuticals | 99.67M |
| Kazia Therapeutics | 99.35M |
| Black Diamond Therapeutics | 98.82M |
| ImmuCell | 97.63M |
| NeurAxis | 96.69M |
| Immunic | 95.10M |
| Polaryx Therapeutics | 93.71M |